We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$138M
AUM Growth
+$3.81M
Cap. Flow
+$4.2M
Cap. Flow %
3.03%
Top 10 Hldgs %
35.89%
Holding
98
New
17
Increased
24
Reduced
4
Closed
13

Top Buys

Rank Stock Value
1
AVIR icon
Atea Pharmaceuticals
AVIR
+$2.7M
2
CTRA
Coterra Energy
CTRA
+$2.04M
3
BP icon
BP
BP
+$1.57M
4
INTC icon
Intel
INTC
+$1.47M
5
C icon
Citigroup
C
+$1.18M

Top Sells

Rank Stock Value
1
INTT icon
inTEST
INTT
+$2.95M
2
MRK icon
Merck
MRK
+$1.85M
3
EXEL icon
Exelixis
EXEL
+$1.81M
4
SWN
Southwestern Energy Company
SWN
+$1.63M
5
ET icon
Energy Transfer Partners
ET
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 36.58%
2 Financials 14.24%
3 Technology 13.07%
4 Energy 11.74%
5 Materials 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NHC icon
26
National Healthcare
NHC
$3.46B
$1.75M 1.26%
25,000
+5,000
+25% +$363K
TAST
27
DELISTED
Carrols Restaurant Group, Inc.
TAST
$1.74M 1.26%
290,000
+31,435
+12% +$186K
VTRS icon
28
Viatris
VTRS
$20.1B
$1.72M 1.24%
120,000
– –
RNAC icon
29
Cartesian Therapeutics
RNAC
$233M
$1.67M 1.21%
13,333
– –
THFF icon
30
First Financial Corp
THFF
$905M
$1.63M 1.18%
40,000
+4,000
+11% +$177K
BATL icon
31
Battalion Oil
BATL
$38.1M
$1.58M 1.15%
118,289
-1,711
-1% -$21.4K
BP icon
32
BP
BP
$113B
$1.58M 1.15%
+60,000
New +$1.57M
INTC icon
33
Intel
INTC
$504B
$1.4M 1.01%
+25,000
New +$1.47M
CHRS icon
34
Coherus Oncology
CHRS
$221M
$1.38M 1%
100,000
+25,000
+33% +$354K
ARKO icon
35
ARKO Corp
ARKO
$895M
$1.38M 1%
150,000
+20,000
+15% +$204K
VTOL icon
36
Bristow Group
VTOL
$1.34B
$1.36M 0.98%
53,000
– –
NWLI
37
DELISTED
National Western Life Group, Inc. Class A
NWLI
$1.35M 0.97%
6,000
– –
BMY icon
38
Bristol-Myers Squibb
BMY
$126B
$1.34M 0.97%
20,000
– –
IAG icon
39
IAMGOLD
IAG
$8.51B
$1.33M 0.96%
450,000
+100,000
+29% +$337K
BCDA icon
40
BioCardia
BCDA
$13.5M
$1.31M 0.94%
21,933
+1,060
+5% +$64.4K
PTCT icon
41
PTC Therapeutics
PTCT
$6.51B
$1.27M 0.92%
30,000
+5,000
+20% +$214K
CVS icon
42
CVS Health
CVS
$136B
$1.25M 0.9%
15,000
– –
ELTX icon
43
Elicio Therapeutics
ELTX
$82.7M
$1.22M 0.88%
9,375
– –
PAGP icon
44
Plains GP Holdings
PAGP
$5.25B
$1.19M 0.86%
100,000
+30,000
+43% +$320K
PRTK
45
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.19M 0.86%
175,000
+25,000
+17% +$202K
CTSO icon
46
Cytosorbents Corp
CTSO
$22.7M
$1.13M 0.82%
150,000
+30,000
+25% +$253K
C icon
47
Citigroup
C
$221B
$1.13M 0.82%
+16,000
New +$1.18M
AVTA
48
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.13M 0.81%
65,000
-35,000
-35% -$575K
SPPI
49
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1.13M 0.81%
300,000
– –
SAIC icon
50
Saic
SAIC
$4.93B
$1.1M 0.79%
+12,500
New +$1.12M
1
2
3 4

Similar funds

CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return
WF
WealthPoint Financial Cramerton, North Carolina $119M AUM
SA
SJBenen ADVISORY Chapel Hill, North Carolina $120M AUM

CM Management's Q2 2021 Portfolio in Review

As of Q2 2021, CM Management held 98 positions worth $138M, up 2.8% from $135M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CM Management deployed $4.2M of net new capital in Q2 2021, opening 17 new positions and adding to 24 existing holdings. Its largest new stake was Atea Pharmaceuticals: 90,000 shares worth $1.93M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 41% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was inTEST, an estimated $2.95M trimmed.

  • CM Management's largest Q2 2021 buy was Atea Pharmaceuticals: 90,000 shares worth $1.93M.
  • CM Management added most to Coterra Energy in Q2 2021, an estimated $2.04M increase.
  • CM Management's biggest Q2 2021 reduction was inTEST, cutting an estimated $2.95M.
  • CM Management fully exited Merck in Q2 2021, selling an estimated $1.85M.
  • CM Management's ten largest holdings make up 36% of its $138M portfolio in Q2 2021.
  • CM Management opened 17 new positions and closed 13 in Q2 2021.
  • CM Management's portfolio value rose 2.8% quarter-over-quarter to $138M.

Based on CM Management's 13F filing for Q2 2021, filed 10 Aug 2021.